Global Parkinson's Disease Drug Market Research Report 2017

December 2017 | 117 pages | ID: G99206E4D53EN
QYResearch

Abstracts

In this report, the global Parkinson's Disease Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Parkinson's Disease Drug in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Parkinson's Disease Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Merck
• Akorn
• GSK
• Novartis
• Boehringer Ingelheim
• Teva Pharmaceutical
• Abbvie
• Kyowa Hakko Kirin Pharma
• Astellas Pharma
• Desitin Arzneimittel
• Endo Pharmaceuticals
• F.Hoffmann-La Roche
• H.Lundbeck
• Valeant
• Apokyn
• Orion
• Stada Arzneimittel
• US WorldMeds
• Valeant Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Sinemet-CR
• Trastal
• Madopar
• COMT Inhibitor
• Other

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Under 40 Years Old
• 40-65 Years Old
• Above 65 Years Old

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Parkinson's Disease Drug Market Research Report 2017

1 PARKINSON'S DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Parkinson's Disease Drug
1.2 Parkinson's Disease Drug Segment by Type (Product Category)
  1.2.1 Global Parkinson's Disease Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Parkinson's Disease Drug Production Market Share by Type (Product Category) in 2016
  1.2.3 Sinemet-CR
  1.2.4 Trastal
  1.2.5 Madopar
  1.2.6 COMT Inhibitor
  1.2.7 Other
1.3 Global Parkinson's Disease Drug Segment by Application
  1.3.1 Parkinson's Disease Drug Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Under 40 Years Old
  1.3.3 40-65 Years Old
  1.3.4 Above 65 Years Old
1.4 Global Parkinson's Disease Drug Market by Region (2012-2022)
  1.4.1 Global Parkinson's Disease Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Parkinson's Disease Drug (2012-2022)
  1.5.1 Global Parkinson's Disease Drug Revenue Status and Outlook (2012-2022)
  1.5.2 Global Parkinson's Disease Drug Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL PARKINSON'S DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Parkinson's Disease Drug Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Parkinson's Disease Drug Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Parkinson's Disease Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Parkinson's Disease Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Parkinson's Disease Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Parkinson's Disease Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Parkinson's Disease Drug Market Competitive Situation and Trends
  2.5.1 Parkinson's Disease Drug Market Concentration Rate
  2.5.2 Parkinson's Disease Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PARKINSON'S DISEASE DRUG CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Parkinson's Disease Drug Capacity and Market Share by Region (2012-2017)
3.2 Global Parkinson's Disease Drug Production and Market Share by Region (2012-2017)
3.3 Global Parkinson's Disease Drug Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL PARKINSON'S DISEASE DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Parkinson's Disease Drug Consumption by Region (2012-2017)
4.2 North America Parkinson's Disease Drug Production, Consumption, Export, Import (2012-2017)
4.3 Europe Parkinson's Disease Drug Production, Consumption, Export, Import (2012-2017)
4.4 China Parkinson's Disease Drug Production, Consumption, Export, Import (2012-2017)
4.5 Japan Parkinson's Disease Drug Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Parkinson's Disease Drug Production, Consumption, Export, Import (2012-2017)
4.7 India Parkinson's Disease Drug Production, Consumption, Export, Import (2012-2017)

5 GLOBAL PARKINSON'S DISEASE DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Parkinson's Disease Drug Production and Market Share by Type (2012-2017)
5.2 Global Parkinson's Disease Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Parkinson's Disease Drug Price by Type (2012-2017)
5.4 Global Parkinson's Disease Drug Production Growth by Type (2012-2017)

6 GLOBAL PARKINSON'S DISEASE DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Parkinson's Disease Drug Consumption and Market Share by Application (2012-2017)
6.2 Global Parkinson's Disease Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL PARKINSON'S DISEASE DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Merck
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Parkinson's Disease Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Merck Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Akorn
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Parkinson's Disease Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Akorn Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 GSK
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Parkinson's Disease Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 GSK Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Novartis
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Parkinson's Disease Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Novartis Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Boehringer Ingelheim
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Parkinson's Disease Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Boehringer Ingelheim Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Teva Pharmaceutical
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Parkinson's Disease Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Teva Pharmaceutical Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Abbvie
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Parkinson's Disease Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Abbvie Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Kyowa Hakko Kirin Pharma
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Parkinson's Disease Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Astellas Pharma
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Parkinson's Disease Drug Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Astellas Pharma Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Desitin Arzneimittel
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Parkinson's Disease Drug Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Desitin Arzneimittel Parkinson's Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Endo Pharmaceuticals
7.12 F.Hoffmann-La Roche
7.13 H.Lundbeck
7.14 Valeant
7.15 Apokyn
7.16 Orion
7.17 Stada Arzneimittel
7.18 US WorldMeds
7.19 Valeant Pharmaceuticals

8 PARKINSON'S DISEASE DRUG MANUFACTURING COST ANALYSIS

8.1 Parkinson's Disease Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Parkinson's Disease Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Parkinson's Disease Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PARKINSON'S DISEASE DRUG MARKET FORECAST (2017-2022)

12.1 Global Parkinson's Disease Drug Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Parkinson's Disease Drug Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Parkinson's Disease Drug Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Parkinson's Disease Drug Price and Trend Forecast (2017-2022)
12.2 Global Parkinson's Disease Drug Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Parkinson's Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Parkinson's Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Parkinson's Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Parkinson's Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Parkinson's Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Parkinson's Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Parkinson's Disease Drug Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Parkinson's Disease Drug Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinson's Disease Drug
Figure Global Parkinson's Disease Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Parkinson's Disease Drug Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Sinemet-CR
Table Major Manufacturers of Sinemet-CR
Figure Product Picture of Trastal
Table Major Manufacturers of Trastal
Figure Product Picture of Madopar
Table Major Manufacturers of Madopar
Figure Product Picture of COMT Inhibitor
Table Major Manufacturers of COMT Inhibitor
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Parkinson's Disease Drug Consumption (K Units) by Applications (2012-2022)
Figure Global Parkinson's Disease Drug Consumption Market Share by Applications in 2016
Figure Under 40 Years Old Examples
Table Key Downstream Customer in Under 40 Years Old
Figure 40-65 Years Old Examples
Table Key Downstream Customer in 40-65 Years Old
Figure Above 65 Years Old Examples
Table Key Downstream Customer in Above 65 Years Old
Figure Global Parkinson's Disease Drug Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Parkinson's Disease Drug Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Parkinson's Disease Drug Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Parkinson's Disease Drug Major Players Product Capacity (K Units) (2012-2017)
Table Global Parkinson's Disease Drug Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Parkinson's Disease Drug Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Parkinson's Disease Drug Capacity (K Units) of Key Manufacturers in 2016
Figure Global Parkinson's Disease Drug Capacity (K Units) of Key Manufacturers in 2017
Figure Global Parkinson's Disease Drug Major Players Product Production (K Units) (2012-2017)
Table Global Parkinson's Disease Drug Production (K Units) of Key Manufacturers (2012-2017)
Table Global Parkinson's Disease Drug Production Share by Manufacturers (2012-2017)
Figure 2016 Parkinson's Disease Drug Production Share by Manufacturers
Figure 2017 Parkinson's Disease Drug Production Share by Manufacturers
Figure Global Parkinson's Disease Drug Major Players Product Revenue (Million USD) (2012-2017)
Table Global Parkinson's Disease Drug Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Parkinson's Disease Drug Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Parkinson's Disease Drug Revenue Share by Manufacturers
Table 2017 Global Parkinson's Disease Drug Revenue Share by Manufacturers
Table Global Market Parkinson's Disease Drug Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Parkinson's Disease Drug Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Parkinson's Disease Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Parkinson's Disease Drug Product Category
Figure Parkinson's Disease Drug Market Share of Top 3 Manufacturers
Figure Parkinson's Disease Drug Market Share of Top 5 Manufacturers
Table Global Parkinson's Disease Drug Capacity (K Units) by Region (2012-2017)
Figure Global Parkinson's Disease Drug Capacity Market Share by Region (2012-2017)
Figure Global Parkinson's Disease Drug Capacity Market Share by Region (2012-2017)
Figure 2016 Global Parkinson's Disease Drug Capacity Market Share by Region
Table Global Parkinson's Disease Drug Production by Region (2012-2017)
Figure Global Parkinson's Disease Drug Production (K Units) by Region (2012-2017)
Figure Global Parkinson's Disease Drug Production Market Share by Region (2012-2017)
Figure 2016 Global Parkinson's Disease Drug Production Market Share by Region
Table Global Parkinson's Disease Drug Revenue (Million USD) by Region (2012-2017)
Table Global Parkinson's Disease Drug Revenue Market Share by Region (2012-2017)
Figure Global Parkinson's Disease Drug Revenue Market Share by Region (2012-2017)
Table 2016 Global Parkinson's Disease Drug Revenue Market Share by Region
Figure Global Parkinson's Disease Drug Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Parkinson's Disease Drug Consumption (K Units) Market by Region (2012-2017)
Table Global Parkinson's Disease Drug Consumption Market Share by Region (2012-2017)
Figure Global Parkinson's Disease Drug Consumption Market Share by Region (2012-2017)
Figure 2016 Global Parkinson's Disease Drug Consumption (K Units) Market Share by Region
Table North America Parkinson's Disease Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Parkinson's Disease Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Parkinson's Disease Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Parkinson's Disease Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Parkinson's Disease Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Parkinson's Disease Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Parkinson's Disease Drug Production (K Units) by Type (2012-2017)
Table Global Parkinson's Disease Drug Production Share by Type (2012-2017)
Figure Production Market Share of Parkinson's Disease Drug by Type (2012-2017)
Figure 2016 Production Market Share of Parkinson's Disease Drug by Type
Table Global Parkinson's Disease Drug Revenue (Million USD) by Type (2012-2017)
Table Global Parkinson's Disease Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Parkinson's Disease Drug by Type (2012-2017)
Figure 2016 Revenue Market Share of Parkinson's Disease Drug by Type
Table Global Parkinson's Disease Drug Price (USD/Unit) by Type (2012-2017)
Figure Global Parkinson's Disease Drug Production Growth by Type (2012-2017)
Table Global Parkinson's Disease Drug Consumption (K Units) by Application (2012-2017)
Table Global Parkinson's Disease Drug Consumption Market Share by Application (2012-2017)
Figure Global Parkinson's Disease Drug Consumption Market Share by Applications (2012-2017)
Figure Global Parkinson's Disease Drug Consumption Market Share by Application in 2016
Table Global Parkinson's Disease Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Parkinson's Disease Drug Consumption Growth Rate by Application (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Parkinson's Disease Drug Production Growth Rate (2012-2017)
Figure Merck Parkinson's Disease Drug Production Market Share (2012-2017)
Figure Merck Parkinson's Disease Drug Revenue Market Share (2012-2017)
Table Akorn Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Akorn Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Akorn Parkinson's Disease Drug Production Growth Rate (2012-2017)
Figure Akorn Parkinson's Disease Drug Production Market Share (2012-2017)
Figure Akorn Parkinson's Disease Drug Revenue Market Share (2012-2017)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Parkinson's Disease Drug Production Growth Rate (2012-2017)
Figure GSK Parkinson's Disease Drug Production Market Share (2012-2017)
Figure GSK Parkinson's Disease Drug Revenue Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Parkinson's Disease Drug Production Growth Rate (2012-2017)
Figure Novartis Parkinson's Disease Drug Production Market Share (2012-2017)
Figure Novartis Parkinson's Disease Drug Revenue Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Production Growth Rate (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Production Market Share (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Revenue Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Production Growth Rate (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Production Market Share (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Revenue Market Share (2012-2017)
Table Abbvie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbvie Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbvie Parkinson's Disease Drug Production Growth Rate (2012-2017)
Figure Abbvie Parkinson's Disease Drug Production Market Share (2012-2017)
Figure Abbvie Parkinson's Disease Drug Revenue Market Share (2012-2017)
Table Kyowa Hakko Kirin Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Growth Rate (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Market Share (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Revenue Market Share (2012-2017)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Production Growth Rate (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Production Market Share (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Revenue Market Share (2012-2017)
Table Desitin Arzneimittel Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Desitin Arzneimittel Parkinson's Disease Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Production Growth Rate (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Production Market Share (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease Drug
Figure Manufacturing Process Analysis of Parkinson's Disease Drug
Figure Parkinson's Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2016
Table Major Buyers of Parkinson's Disease Drug
Table Distributors/Traders List
Figure Global Parkinson's Disease Drug Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Parkinson's Disease Drug Price (Million USD) and Trend Forecast (2017-2022)
Table Global Parkinson's Disease Drug Production (K Units) Forecast by Region (2017-2022)
Figure Global Parkinson's Disease Drug Production Market Share Forecast by Region (2017-2022)
Table Global Parkinson's Disease Drug Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Parkinson's Disease Drug Consumption Market Share Forecast by Region (2017-2022)
Figure North America Parkinson's Disease Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Parkinson's Disease Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Parkinson's Disease Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Parkinson's Disease Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Parkinson's Disease Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Parkinson's Disease Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Parkinson's Disease Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Parkinson's Disease Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Parkinson's Disease Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Parkinson's Disease Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Parkinson's Disease Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Parkinson's Disease Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Parkinson's Disease Drug Production (K Units) Forecast by Type (2017-2022)
Figure Global Parkinson's Disease Drug Production (K Units) Forecast by Type (2017-2022)
Table Global Parkinson's Disease Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Parkinson's Disease Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Parkinson's Disease Drug Price Forecast by Type (2017-2022)
Table Global Parkinson's Disease Drug Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Parkinson's Disease Drug Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source